Gianfranco Nazzi

Gianfranco Nazzi has a diverse work experience spanning various industries. Gianfranco is currently the Chief Executive Officer at Biofarma Group since February 2023. Prior to that, they served as the Chief Executive Officer at Almirall from May 2021 to November 2022. Gianfranco held multiple roles at Teva Pharmaceuticals from 2014 to 2021, including Executive Vice President, International Markets, and Member of the Teva Executive Committee. Before that, they worked at AstraZeneca as the Sales and Marketing Vice President Europe and held other leadership positions. Gianfranco also worked at GlaxoSmithKline as the BU Director Metabolic & CV and at Eli Lilly in various sales and marketing roles. Nazzi began their career at Danieli in the Administrative Department.

Gianfranco Nazzi completed an MBA from SDA Bocconi in 1998-1999. Prior to that, they studied economy at the Università degli Studi di Udine, but no specific dates were provided.